Background:  Prostate artery embolization (PAE) is a new embolization therapy to treat benign prostate syndrome (BPS).

Materials And Methods:  This review article presents the rationale and impact mechanism of PAE, criteria for patient selection, and discusses the anatomy of prostate arteries. The study results are seen in the context of complications and clinical partners.

Results:  Important preconditions for successful prostate artery embolization are a strict indication, precise knowledge of the anatomy of the pelvic arteries and advanced interventional-radiological skills. Several studies showed that urological parameters after prostate artery embolization improve at a similar level as for established post-surgical treatments. At the same time, it could be proven that prostate artery embolization has no impact on erectile function and is associated with a relatively low complication rate.

Conclusion:  PAE is increasingly developing to an alternative for the established surgical treatments in BPS patients.

Key Points:   · PAE is a new embolization method for treating BPS and represents an alternative to classic urological surgical procedure such as TURP.. · Due to the low caliber of the prostate artery (0.5 - 2 mm), the presence of anatomical variations, and the arteriosclerosis seen in most older men, PAE is a technically challenging embolization method.. · In patients with a high postoperative bleeding risk in classic urological surgical treatment concepts, PAE is a very gentle alternative method..

Citation Format: · Teichgräber U, Aschenbach R, Diamantis I et al. Prostate Artery Embolization: Indication, Technique and Clinical Results. Fortschr Röntgenstr 2018; 190: 847 - 855.

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0612-8067DOI Listing

Publication Analysis

Top Keywords

prostate artery
24
artery embolization
24
embolization
9
prostate
8
embolization indication
8
indication technique
8
technique clinical
8
pae embolization
8
embolization method
8
classic urological
8

Similar Publications

BACKGROUND Despite its surgical complexity, kidney transplantation (KT) with multiple renal arteries (MRA) is comparable in performance to KT with a single renal artery (SRA). This study aimed to evaluate the effect of MRA and to investigate risk factors for graft loss in living-donor KT with MRA. MATERIAL AND METHODS This study included living-donor KT recipients who underwent KT in our hospital from February 2002 to March 2023.

View Article and Find Full Text PDF

Potential beneficial impacts of tadalafil on cardiovascular diseases.

J Chin Med Assoc

January 2025

Department and Institute of Pharmacology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.

Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor commonly used for the treatment of erectile dysfunction and benign prostatic hyperplasia. Its mechanism of action involves the inhibition of PDE5, leading to increased levels of nitric oxide and cyclic guanosine monophosphate in the corpus cavernosum, which facilitates smooth muscle relaxation. This article reviews studies using tadalafil in the treatment of cardiovascular diseases and emphasizes its potential advantages in conditions such as pulmonary arterial hypertension, atherosclerosis, coronary artery disease, myocardial infarction, heart failure, stroke, diabetic ulcers, and cardiomyopathy.

View Article and Find Full Text PDF

Background: Androgen deprivation is associated with erectile dysfunction (ED). In different animal models, sulfur dioxide (SO) donors NaSO and NaHSO reduced oxidative stress, fibrosis, and inflammation which contribute to the pathogenesis of androgen deprivation-induced ED, however the effect of SO donors on ED in castrated rats were not known.

Objective: To investigate the therapeutic effect of SO donors, NaSO/NaHSO, on ED in castrated rat model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!